MIRM News and Press, Mirum Pharmaceuticals Inc.

- Phase 3 AZURE-1 enrollment complete - Phase 3 AZURE-4 screening complete - Topline AZURE-1 and AZURE-4 results expected in 2H 2026 - AZURE-1 and AZURE-4 to form the basis of Mirum’s U.S. BLA Submission Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a le...

2026-03-04 09:03:39 ET Gavin Clark-Gartner from Evercore ISI issued a price target of $126.00 for MIRM on 2026-03-04 13:27:00. The adjusted price target was set to $126.00. At the time of the announcement, MIRM was trading at $89.37. The overall price target consensus is...

2026-02-26 12:03:43 ET Mani Foroohar from Leerink Partners issued a price target of $118.00 for MIRM on 2026-02-26 15:52:00. The adjusted price target was set to $118.00. At the time of the announcement, MIRM was trading at $92.78. The overall price target consensus is a...

2026-02-26 11:15:03 ET Evercore ISI analyst issues OUTPERFORM recommendation for MIRM on February 26, 2026 03:50PM ET. The previous analyst recommendation was Outperform. MIRM was trading at $94 at issue of the analyst recommendation. The overall analyst consensus : BUY....

2026-02-26 11:15:02 ET Leerink Partners analyst issues OUTPERFORM recommendation for MIRM on February 26, 2026 03:52PM ET. The previous analyst recommendation was Outperform. MIRM was trading at $93.46 at issue of the analyst recommendation. The overall analyst consensus...

2026-02-26 11:03:51 ET Joe Kim from RBC Capital issued a price target of $128.00 for MIRM on 2026-02-26 15:40:00. The adjusted price target was set to $128.00. At the time of the announcement, MIRM was trading at $94.14. The overall price target consensus is at $112.60 w...

2026-02-26 09:23:12 ET Mirum Pharmaceuticals ( MIRM ) just reported its 4Q, its full year topline clocking in at $521 million , up 55% from the prior year. Though the quarter's net income disappointed, the call cemented a banner year and provided investors with further insights ...

2026-02-25 18:38:42 ET More on Mirum Pharmaceuticals Mirum Pharmaceuticals, Inc. (MIRM) Q4 2025 Earnings Call Transcript Mirum Pharmaceuticals, Inc. (MIRM) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Mirum Pharmaceuticals: Rich In 2025, Riche...

2026-02-25 18:37:54 ET Mirum Pharmaceuticals, Inc. (MIRM) Q4 2025 Earnings Call February 25, 2026 4:30 PM EST... Read the full article on Seeking Alpha For further details see: Mirum Pharmaceuticals, Inc. (MIRM) Q4 2025 Earnings Call Transcript

2026-02-25 17:51:32 ET Image source: The Motley Fool. Wednesday, Feb. 25, 2026, at 4:30 p.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading